Deoxyguanosine Kinase Antikörper (N-Term)

Produktnummer ABIN391122

Produktdetails anti-Deoxyguanosine Kinase Antikörper

Target: Deoxyguanosine Kinase (DGUOK)

Bindungsspezifität: AA 1-30, N-Term

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Deoxyguanosine Kinase Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

Immunogen: This Deoxyguanosine Kinase (DGUOK) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human Deoxyguanosine Kinase (DGUOK).

Klon: RB5277

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000. WB: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Haltbarkeit: 6 months

Details zu Deoxyguanosine Kinase

Target: Deoxyguanosine Kinase (DGUOK)

Abstract: DGUOK Produkte

Synonyme: DGUOK antikoerper, zgc:86625 antikoerper, dgk antikoerper, DDBDRAFT_0218264 antikoerper, DDBDRAFT_0233982 antikoerper, DDB_0218264 antikoerper, DDB_0233982 antikoerper, MTDPS3 antikoerper, dGK antikoerper, dGK1 antikoerper, dGK2 antikoerper, dGK3 antikoerper, deoxyguanosine kinase antikoerper, deoxyguanosine kinase L homeolog antikoerper, DGUOK antikoerper, dguok antikoerper, dguok.L antikoerper, dgk antikoerper, Ccan_04750 antikoerper, Dguok antikoerper

Hintergrund: Mitochondrial deoxyguanosine kinase (DGUOK) is required for the phosphorylation of several deoxyribonucleosides and certain purine deoxykribonucleoside analogs widely employed as antiviral and chemotherapeutic agents. Purine deoxyribonucleoside analogs are extensively used in treatment of lymphoproliferative disorders. These compounds are administered as pro-drugs, and their efficiency is dependent on intracellular phosphorylation to the corresponding triphosphates. In mammalian cells, the phosphorylation of purine deoxyribonucleosides is mediated predominantly by 2 deoxyribonucleoside kinases: cytosolic deoxycytidine kinase (DCK) and mitochondrial deoxyguanosine kinase (DGUOK also known as DGK). DGUOK expression is ubiquitous, with highest levels in muscle, brain, liver and lymphoid tissues. Defects in DGUOK are a cause of mitochondrial DNA depletion syndrome (MDS). MDS is a clinically heterogeneous group of disorders characterized by a reduction in mitochondrial DNA (mtDNA) copy number. Primary mtDNA depletion is inherited as an autosomal recessive trait and may affect single organs, typically muscle or liver, or multiple tissues. Mitochondrial DNA depletion syndromes are phenotypically heterogeneous, autosomal recessive disorders characterized by tissue-specific reduction in mtDNA copy number. Affected individuals with the hepatocerebral form of mtDNA depletion syndrome have early progressive liver failure and neurologic abnormalities, hypoglycemia, and increased lactate in body fluids.

Molekulargewicht: 32056

Gen-ID: 1716

NCBI Accession: NP_550438, NP_550440

UniProt: Q16854

Pathways: Ribonucleoside Biosynthetic Process